dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Rojano Toimil, Alba |
dc.contributor.author | Rivera Esteban, Jesus Manuel |
dc.contributor.author | Manzano Nuñez, Ramiro |
dc.contributor.author | Juan Bañares Sanchez, Juan |
dc.contributor.author | Gabriel Medina, Pablo |
dc.contributor.author | Ferrer Costa, Roser |
dc.contributor.author | Pericàs Pulido, Juan Manuel |
dc.contributor.author | Ciudin Mihai, Andreea |
dc.contributor.author | Martinez Selva, David |
dc.date.accessioned | 2022-09-12T09:30:12Z |
dc.date.available | 2022-09-12T09:30:12Z |
dc.date.issued | 2022-06-08 |
dc.identifier.citation | Rojano-Toimil A, Rivera-Esteban J, Manzano-Nuñez R, Bañares J, Martinez Selva D, Gabriel-Medina P, et al. When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD. J Clin Med. 2022 Jun 8;11(12):3286. |
dc.identifier.issn | 2077-0383 |
dc.identifier.uri | https://hdl.handle.net/11351/8148 |
dc.description | Diabetis MODY; Fibrosi hepàtica; Diabetis tipus 2 |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Journal of Clinical Medicine;11(12) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Fenotip |
dc.subject | Diabetis no-insulinodependent |
dc.subject | Esteatosi hepàtica - Diagnòstic |
dc.subject.mesh | Diabetes Mellitus, Type 2 |
dc.subject.mesh | Non-alcoholic Fatty Liver Disease |
dc.subject.mesh | /diagnosis |
dc.subject.mesh | Phenotype |
dc.title | When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/jcm11123286 |
dc.subject.decs | diabetes mellitus tipo II |
dc.subject.decs | esteatosis hepática no alcohólica |
dc.subject.decs | /diagnóstico |
dc.subject.decs | fenotipo |
dc.relation.publishversion | https://doi.org/10.3390/jcm11123286 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Rojano-Toimil A] Servei d’Endocrinologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Rivera-Esteban J] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Unitat Hepàtica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Manzano-Nuñez R, Bañares J] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Unitat Hepàtica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Martinez Selva D] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Spanish Network of Biomedical Research Centers, Diabetes and Metabolic Associated Disorders (CIBERdem), Madrid, Spain. [Gabriel-Medina P] Servei de Bioquímica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Ferrer R] Servei de Bioquímica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Pericàs JM] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Unitat Hepàtica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Spanish Network of Biomedical Research Centers, Liver and Digestive Diseases (CIBERehd), Madrid, Spain. [Ciudin A] Servei d’Endocrinologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Spanish Network of Biomedical Research Centers, Diabetes and Metabolic Associated Disorders (CIBERdem), Madrid, Spain |
dc.identifier.pmid | 35743358 |
dc.identifier.wos | 000817683200001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |